Celeste Krewson, Assistant Editor

At the 2024 Annual Meeting of The Menopause Society, the positive safety and efficacy data of fezolinetant against sleep disturbances from the SKYLIGHT 1 and 2 trials was presented.

The phase 3 OASIS trial presented at the 2024 Annual Meeting of The Menopause Society displayed significant improvements in the frequency of moderate-to-severe vasomotor symptoms among patients receiving elinzanetant.

Low rates of hormone therapy use have been reported among midlife women, stagnating after decreases in the immediate aftermath of the Women’s Health Initiative.

In a recent study presented at the 2024 Annual Meeting of The Menopause Society, insulin resistance was significantly reduced among postmenopausal women receiving hormone therapy vs placebo.

In a recent study presented at the 2024 Annual Meeting of The Menopause Society, 23% of patients with breast arterial calcifications on a mammogram had atherosclerotic cardiovascular disease, vs 13.9% without.

In a recent study presented at the 2024 Annual Meeting of The Menopause Society, the prevalence of Alzheimer’s disease was significantly increased among women with prior trauma.

In a recent study presented at the 2024 Annual Meeting of The Menopause Society, women with certain adverse outcomes during pregnancy had an increased risk of cardiovascular disease later in life.

Amanda Williams, MD, MPH, FACOG, Interim Chief Medical Officer at March of Dimes, discusses the reported increase in the number of US counties with no obstetric care providers.

In a recent study presented at the 2024 Annual Meeting of The Menopause Society, 59% of nocturnal hot flashes occurred during the second half of the night, a time linked to increased cardiovascular disease risk.

Data presented at the 2024 Annual Meeting of The Menopause Society highlighted greater reductions in hot flash severity among women receiving clinical hypnosis compared to those receiving cognitive behavioral therapy.

In a recent study, women with urinary incontinence were more likely to experience postpartum depression at both under and over 6 months after delivery.

Review some of the top stories from the Contemporary OB/GYN website over the last week, and catch up on anything you may have missed.

The advisory committee meeting will discuss the potential approval of oral sulopenem etzadroxil/probenecid tablets for treating urinary tract infections in women aged 18 years and older.

In a recent study, neurodevelopmental outcomes did not significantly differ among children exposed to metformin in utero vs those unexposed.

In a recent study, women with higher levels of per- and polyfluoroalkyl substances during pregnancy reported increased weight and body fat later in life.

The new single-handed inserter by CooperSurgical streamlines the placement of Paragard, a hormone-free IUD with over 30 years of proven efficacy, enhancing accessibility for both health care providers and patients.

In a recent study, rates of 12-month or longer contraceptive supply were increased by the implementation of a 12-month contraceptive supply policy.

In a recent study, the odds of adverse pregnancy outcomes were significantly increased in pregnancies of women with solid organ transplants.

In a recent study, reduced aging discrepancies were observed in postmenopausal women reporting hormone therapy use vs nonusers.

Review some of the top stories from the Contemporary OB/GYN website over the last week, and catch up on anything you may have missed.

In a recent study, only mothers with a COX1 rs1330344 TT genotype had reduced offspring atopic dermatitis risk following fish oil supplementation.

Jean Dubuisson, MD, PhD, head of the gynecological surgery unit at Geneva University Hospitals, discusses the first successful hysterectomy performed using the MIRA surgical system.

Astellas Pharma has announced the first dose administration of fezolinetant to manage moderate to severe vasomotor symptoms in breast cancer patients using adjuvant endocrine therapy.

In a recent study, older women receiving messages about breast cancer screening cessation were more likely to support stopping screening than those who did not receive a message.

In a recent study, women overdue for cervical cancer and colorectal cancer screening were more likely to receive coverage when offered during their breast cancer screening visit.

In a recent study published in The Journal of Sexual Medicine, Sildenafil Cream, 3.6% was indicated as safe and well-tolerated for use against female sexual arousal disorder in healthy premenopausal women.

In a recent study, the accuracy of an artificial intelligence tool operated by novice users with no prior ultrasonography training for estimating gestational age was similar to that of expert sonographers conducting standard biometry.

Following the Supreme Court’s decision to retain mifepristone access in June 2024, health care providers have spoken out about the need to fight for reproductive health care protections on a national and local level.

In a recent study, older women with type 2 diabetes had a higher bone mineral density but reduced physical function, linking the reduction in physical function to increased fracture risk in this population.

A recent study found that women with a shorter reproductive lifespan had increased odds of multimorbidity compared to those with a longer reproductive lifespan, indicating a need to assess reproductive factors to determine high-risk patients.